Ono Pharmaceutical Co., Ltd. (4528.T)
JPY 1682.5
(3.67%)
JPY 1682.5
(3.67%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 266.61 JPY | 15.49% |
| 2022 | 230.85 JPY | 42.33% |
| 2021 | 162.19 JPY | 7.33% |
| 2020 | 151.11 JPY | 27.55% |
| 2019 | 118.47 JPY | 18.17% |
| 2018 | 100.25 JPY | 3.35% |
| 2017 | 97.00 JPY | -7.86% |
| 2016 | 105.27 JPY | 123.36% |
| 2015 | 47.13 JPY | 861.84% |
| 2014 | 4.90 JPY | -36.2% |
| 2013 | 7.68 JPY | -82.24% |
| 2012 | 43.24 JPY | -5.92% |
| 2011 | 45.96 JPY | 2.64% |
| 2010 | 44.78 JPY | -12.68% |
| 2009 | 51.28 JPY | 18.65% |
| 2008 | 43.22 JPY | -29.57% |
| 2007 | 61.37 JPY | 1.35% |
| 2006 | 60.55 JPY | -1.5% |
| 2005 | 61.47 JPY | -7.99% |
| 2004 | 66.81 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 52.79 JPY | 40.62% |
| 2024 Q2 | 35.87 JPY | -31.99% |
| 2023 Q2 | 88.18 JPY | 35.33% |
| 2023 Q1 | 65.16 JPY | 86.44% |
| 2023 FY | - JPY | 15.49% |
| 2023 Q4 | 37.54 JPY | -50.46% |
| 2023 Q3 | 75.77 JPY | -14.07% |
| 2022 Q2 | 67.30 JPY | 11.48% |
| 2022 Q4 | 34.95 JPY | -48.78% |
| 2022 Q3 | 68.23 JPY | 1.38% |
| 2022 FY | - JPY | 42.33% |
| 2022 Q1 | 60.37 JPY | 86.1% |
| 2021 Q2 | 44.51 JPY | -7.71% |
| 2021 Q1 | 48.23 JPY | 169.29% |
| 2021 Q3 | 36.83 JPY | -17.25% |
| 2021 Q4 | 32.44 JPY | -11.92% |
| 2021 FY | - JPY | 7.33% |
| 2020 Q1 | 43.07 JPY | 170.37% |
| 2020 Q2 | 36.77 JPY | -14.63% |
| 2020 Q3 | 53.37 JPY | 45.15% |
| 2020 Q4 | 17.91 JPY | -66.44% |
| 2020 FY | - JPY | 27.55% |
| 2019 FY | - JPY | 18.17% |
| 2019 Q4 | 15.93 JPY | -58.18% |
| 2019 Q3 | 38.09 JPY | 16.38% |
| 2019 Q2 | 32.73 JPY | 2.8% |
| 2019 Q1 | 31.84 JPY | 94.74% |
| 2018 Q1 | 29.64 JPY | 71.73% |
| 2018 Q4 | 16.35 JPY | -41.17% |
| 2018 Q3 | 27.79 JPY | 4.99% |
| 2018 FY | - JPY | 3.35% |
| 2018 Q2 | 26.47 JPY | -10.7% |
| 2017 Q1 | 22.31 JPY | -11.26% |
| 2017 FY | - JPY | -7.86% |
| 2017 Q4 | 17.26 JPY | -56.14% |
| 2017 Q3 | 39.35 JPY | 115.26% |
| 2017 Q2 | 18.28 JPY | -18.06% |
| 2016 Q1 | 25.81 JPY | 135.92% |
| 2016 FY | - JPY | 123.36% |
| 2016 Q4 | 25.14 JPY | -31.14% |
| 2016 Q3 | 36.51 JPY | 105.0% |
| 2016 Q2 | 17.81 JPY | -31.0% |
| 2015 Q1 | 17.83 JPY | 446.21% |
| 2015 FY | - JPY | 861.84% |
| 2015 Q4 | 10.94 JPY | -20.67% |
| 2015 Q3 | 13.79 JPY | 201.75% |
| 2015 Q2 | 4.57 JPY | -74.37% |
| 2014 Q4 | -5.15 JPY | -121.96% |
| 2014 Q1 | 5.49 JPY | 118.4% |
| 2014 Q2 | 0.70 JPY | -87.25% |
| 2014 Q3 | 23.45 JPY | 3250.0% |
| 2014 FY | - JPY | -36.2% |
| 2013 Q1 | 15.08 JPY | 304.29% |
| 2013 FY | - JPY | -82.24% |
| 2013 Q3 | 15.76 JPY | 135.93% |
| 2013 Q4 | -29.84 JPY | -289.34% |
| 2013 Q2 | 6.68 JPY | -55.7% |
| 2012 Q1 | 15.89 JPY | 25.91% |
| 2012 FY | - JPY | -5.92% |
| 2012 Q4 | 3.73 JPY | -79.97% |
| 2012 Q3 | 18.62 JPY | 272.4% |
| 2012 Q2 | 5.00 JPY | -68.53% |
| 2011 Q3 | 17.53 JPY | 24942.86% |
| 2011 Q2 | 0.07 JPY | -99.56% |
| 2011 FY | - JPY | 2.64% |
| 2011 Q1 | 15.75 JPY | 61.04% |
| 2011 Q4 | 12.62 JPY | -28.01% |
| 2010 Q4 | 9.78 JPY | -45.09% |
| 2010 FY | - JPY | -12.68% |
| 2010 Q3 | 17.81 JPY | 862.7% |
| 2010 Q2 | 1.85 JPY | -87.92% |
| 2010 Q1 | 15.31 JPY | 153.48% |
| 2009 Q3 | 14.76 JPY | 83.13% |
| 2009 FY | - JPY | 18.65% |
| 2009 Q4 | 6.04 JPY | -59.08% |
| 2009 Q2 | 8.06 JPY | -57.58% |
| 2009 Q1 | 19.00 JPY | 290.14% |
| 2008 Q2 | 9.49 JPY | 0.0% |
| 2008 Q4 | 4.87 JPY | -62.01% |
| 2008 FY | - JPY | -29.57% |
| 2008 Q3 | 12.82 JPY | 35.09% |
| 2007 FY | - JPY | 1.35% |
| 2006 FY | - JPY | -1.5% |
| 2005 FY | - JPY | -7.99% |
| 2004 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 151.03 JPY | -76.528% |
| Astellas Pharma Inc. | 9.50 JPY | -2706.421% |
| Chugai Pharmaceutical Co., Ltd. | 197.83 JPY | -34.767% |
| Santen Pharmaceutical Co., Ltd. | 72.62 JPY | -267.13% |
| JCR Pharmaceuticals Co., Ltd. | 44.13 JPY | -504.147% |
| Daiichi Sankyo Company, Limited | 104.69 JPY | -154.666% |
| Otsuka Holdings Co., Ltd. | 224.11 JPY | -18.964% |
| Perseus Proteomics Inc. | -93.69 JPY | 384.566% |